Brief: DocMorris Q2 External Revenue At CHF 267.7 Mln

DocMorris AG

20/08/2024 06:02

Aug 20 (Reuters) - DOCMORRIS AG  DOCM.S :
    * OUTLOOK 2024 REDUCED
    * BREAK-EVEN ACHIEVED EXCLUDING ERX IN FIRST HALF OF 2024
    * OUTLOOK: INCREASE IN EXTERNAL REVENUE BY 5 TO 10 PER CENT,
INCLUDING E-PRESCRIPTIONS (PREVIOUSLY INDICATIVELY MORE THAN 10
PER CENT)
    * OUTLOOK: ADJUSTED EBITDA OF AROUND MINUS CHF 50 MILLION,
INCLUDING E-PRESCRIPTION (PREVIOUSLY INDICATIVELY CHF 0 MILLION
TO MINUS CHF 35 MILLION)
    * OUTLOOK 2024: CAPITAL EXPENDITURE OF AROUND CHF 30 MILLION
(PREVIOUSLY INDICATIVELY CHF 30 MILLION TO CHF 40 MILLION)
    * OUTLOOK: CAPITAL EXPENDITURE OF AROUND CHF 30 MILLION
(PREVIOUSLY INDICATIVELY CHF 30 MILLION TO CHF 40 MILLION)
    * IN MEDIUM TERM, AN ADJUSTED EBITDA MARGIN OF 8 PER CENT
REMAINS
TARGET.
    * Q2 EXTERNAL REVENUE AT CHF 267.7 MILLION

Source text for Eikon:  ID:nEQ3vrxWka 
Further company coverage:  DOCM.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))